rs1799817

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000208.4(INSR):​c.3255C>T​(p.His1085=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.2 in 1,613,618 control chromosomes in the GnomAD database, including 34,069 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.21 ( 3547 hom., cov: 30)
Exomes 𝑓: 0.20 ( 30522 hom. )

Consequence

INSR
NM_000208.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.971
Variant links:
Genes affected
INSR (HGNC:6091): (insulin receptor) This gene encodes a member of the receptor tyrosine kinase family of proteins. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that form a heterotetrameric receptor. Binding of insulin or other ligands to this receptor activates the insulin signaling pathway, which regulates glucose uptake and release, as well as the synthesis and storage of carbohydrates, lipids and protein. Mutations in this gene underlie the inherited severe insulin resistance syndromes including type A insulin resistance syndrome, Donohue syndrome and Rabson-Mendenhall syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant 19-7125286-G-A is Benign according to our data. Variant chr19-7125286-G-A is described in ClinVar as [Benign]. Clinvar id is 194701.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.971 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.387 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
INSRNM_000208.4 linkuse as main transcriptc.3255C>T p.His1085= synonymous_variant 17/22 ENST00000302850.10 NP_000199.2
INSRNM_001079817.3 linkuse as main transcriptc.3219C>T p.His1073= synonymous_variant 16/21 NP_001073285.1
INSRXM_011527988.3 linkuse as main transcriptc.3252C>T p.His1084= synonymous_variant 17/22 XP_011526290.2
INSRXM_011527989.4 linkuse as main transcriptc.3216C>T p.His1072= synonymous_variant 16/21 XP_011526291.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
INSRENST00000302850.10 linkuse as main transcriptc.3255C>T p.His1085= synonymous_variant 17/221 NM_000208.4 ENSP00000303830 A2P06213-1
INSRENST00000341500.9 linkuse as main transcriptc.3219C>T p.His1073= synonymous_variant 16/211 ENSP00000342838 P3P06213-2
INSRENST00000593970.1 linkuse as main transcriptn.101C>T non_coding_transcript_exon_variant 1/32

Frequencies

GnomAD3 genomes
AF:
0.209
AC:
31790
AN:
151870
Hom.:
3538
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.229
Gnomad AMI
AF:
0.114
Gnomad AMR
AF:
0.227
Gnomad ASJ
AF:
0.157
Gnomad EAS
AF:
0.401
Gnomad SAS
AF:
0.324
Gnomad FIN
AF:
0.183
Gnomad MID
AF:
0.272
Gnomad NFE
AF:
0.179
Gnomad OTH
AF:
0.203
GnomAD3 exomes
AF:
0.227
AC:
56640
AN:
249496
Hom.:
7156
AF XY:
0.228
AC XY:
30756
AN XY:
134932
show subpopulations
Gnomad AFR exome
AF:
0.230
Gnomad AMR exome
AF:
0.246
Gnomad ASJ exome
AF:
0.153
Gnomad EAS exome
AF:
0.428
Gnomad SAS exome
AF:
0.312
Gnomad FIN exome
AF:
0.178
Gnomad NFE exome
AF:
0.182
Gnomad OTH exome
AF:
0.208
GnomAD4 exome
AF:
0.199
AC:
290172
AN:
1461630
Hom.:
30522
Cov.:
35
AF XY:
0.202
AC XY:
146547
AN XY:
727134
show subpopulations
Gnomad4 AFR exome
AF:
0.227
Gnomad4 AMR exome
AF:
0.252
Gnomad4 ASJ exome
AF:
0.149
Gnomad4 EAS exome
AF:
0.369
Gnomad4 SAS exome
AF:
0.313
Gnomad4 FIN exome
AF:
0.184
Gnomad4 NFE exome
AF:
0.182
Gnomad4 OTH exome
AF:
0.214
GnomAD4 genome
AF:
0.209
AC:
31836
AN:
151988
Hom.:
3547
Cov.:
30
AF XY:
0.212
AC XY:
15718
AN XY:
74274
show subpopulations
Gnomad4 AFR
AF:
0.229
Gnomad4 AMR
AF:
0.227
Gnomad4 ASJ
AF:
0.157
Gnomad4 EAS
AF:
0.402
Gnomad4 SAS
AF:
0.323
Gnomad4 FIN
AF:
0.183
Gnomad4 NFE
AF:
0.179
Gnomad4 OTH
AF:
0.206
Alfa
AF:
0.188
Hom.:
5353
Bravo
AF:
0.214
Asia WGS
AF:
0.352
AC:
1222
AN:
3478
EpiCase
AF:
0.180
EpiControl
AF:
0.185

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingGeneDxNov 12, 2018This variant is associated with the following publications: (PMID: 19211708, 19926323, 22775283) -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesJan 14, 2021- -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)May 08, 2015- -
Insulin-resistant diabetes mellitus AND acanthosis nigricans Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. -
Rabson-Mendenhall syndrome Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 15, 2018This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -
Leprechaunism syndrome Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.74
CADD
Benign
0.34
DANN
Benign
0.44
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1799817; hg19: chr19-7125297; COSMIC: COSV57158382; COSMIC: COSV57158382; API